Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2023-08-25 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2023年度以简易程序向特定对象发行股票预案（修订稿）
Capital/Financing Update Classification · 100% confidence The document is titled "阳普医疗科技股份有限公司 2023 年度以简易程序向特定对象发行股票预案（修订稿）" which translates to "Improve Medical Instruments Co., Ltd. 2023 Annual Simplified Procedure Private Placement Stock Issuance Plan (Revised Draft)". The content extensively discusses the company's plan to issue new shares to specific investors, including details on the issuance background, purpose, pricing, number of shares, use of proceeds, and regulatory approvals required from the Shenzhen Stock Exchange and China Securities Regulatory Commission. It includes detailed financial and strategic information related to the capital raising event. This is clearly an announcement and detailed plan regarding a capital raising activity through a private placement of shares. It is not a full annual report, earnings release, or other financial report but a capital/financing update document. The document length is substantial (15,000 characters), and it contains the full plan, not just an announcement of a report publication. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-08-25 Chinese
关于2023年度以简易程序向特定对象发行股票预案（修订稿）披露提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (556 characters) regarding a revised plan for a simplified procedure to issue shares to specific targets in 2023. It mentions the board meeting approval and disclosure on a regulatory website but does not contain detailed financial data or the full issuance plan itself. It is an announcement about a capital raising plan, specifically a share issuance plan, rather than the full detailed report or financial statements. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-08-25 Chinese
关于2023年度以简易程序向特定对象发行股票预案修订说明的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the revision of a stock issuance plan to specific investors using a simplified procedure. It details updates to the issuance plan, including the number of shares, pricing, and approval procedures. The document is relatively short (1349 characters) and serves as a formal announcement of changes to a capital raising plan rather than the full detailed report or prospectus itself. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2023-08-25 Chinese
关于子公司与湖南郴州经济开发区管理委员会签署解除招商项目合作合同暨协商收回协议书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Yangpu Medical Technology Co., Ltd. regarding the signing of an agreement to terminate a cooperation contract and recover assets with a local government committee. It details the background, contract terms, asset valuation, payment schedule, and impact on the company. There are no financial statements, quarterly or annual results, or detailed financial analysis. The document is a formal disclosure of a specific transaction related to asset recovery due to policy changes. It is not a full financial report, earnings release, or management discussion. It fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about a contract termination and asset recovery transaction that does not fall under more specific categories like M&A or Capital Update. The document length is 2671 characters, which is relatively short and typical for such announcements.
2023-08-17 Chinese
关于子公司变更名称、经营范围暨完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 阳普医疗科技股份有限公司 regarding the change of name and business scope of its subsidiary, Shenzhen Xirun Financing Leasing Co., Ltd., now renamed Shenzhen Yangpurun Industrial Investment Co., Ltd. It details the changes in the subsidiary's registered business scope and confirms the completion of the industrial and commercial registration changes. The document is a formal public announcement about corporate structural changes, specifically about a subsidiary's name and business scope change, and does not contain financial statements, audit information, or detailed financial data. It is not a report like an annual or interim report, nor is it a regulatory filing about compliance or certification. It is also not a management or board change announcement since it concerns a subsidiary's registration details. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-07-11 Chinese
关于股东签署《不可撤销的表决权放弃协议之补充协议》的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the signing of supplementary agreements to irrevocable voting rights waiver agreements by shareholders of the company. It details changes in voting rights arrangements and their impact on the company, focusing on shareholder agreements and control stability. There are no financial statements, earnings data, or management discussion of financial results. The document is an official announcement about shareholder agreements and voting rights, not a report or detailed financial filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-29 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.